- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06621368
Effect of Two Years of Resistance Training on Health Status in Postmenopausal Women: Longitudinal Study Active Aging.
September 27, 2024 updated by: Edilson Serpeloni Cyrino, Universidade Estadual de Londrina
Effect of Two Years of Resistance Training on Muscular Strength, Body Composition, Functional Fitness, Metabolic Biomarkers, Cognition, and Cardiac Parameters in Postmenopausal Women: Longitudinal Study Active Aging
Aging is a natural process of the life cycle that can result in morphological, neuromuscular, metabolic, physiological, cognitive and behavioral changes that can compromise quality of life, autonomy, self-esteem, health and life expectancy, especially in the elderly.
On the other hand, resistance training (RT) has been widely recommended for the elderly population, due to the numerous health benefits it brings, such as increased strength and muscle mass, reduced body fat, increased bone mineral content and density, and improved cardiometabolic profile, among others.
However, the effectiveness of RT in attenuating or reversing the deleterious effects of aging has been analyzed by studies conducted, in most cases, over relatively short periods, i.e., eight to 24 weeks.
Considering that recent investigations have demonstrated a wide variation in the adaptive responses to RT in this population, it is likely that many of these responses are time-dependent.
Additionally, the influence of important mediators and moderators in this process, especially training intensity and volume, dietary habits, the presence or absence of diseases and degenerative processes that cause disability, and the use of polypharmaceuticals, has not yet been well established.
Therefore, based on the Active Aging Longitudinal Study, a research project initiated in 2012, it is intend to analyze whether or not RT practice can produce positive and lasting adaptive responses on muscle strength, body composition, functional fitness, cognition, cardiometabolic biomarkers, and cardiac function in postmenopausal women, based on a randomized controlled clinical trial over a long period of time (two years).
In addition, mediation and moderation analyses will be used to understand the real impact of RT on the outcomes to be analyzed.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Paraná
-
Londrina, Paraná, Brazil, 86057-970
- Recruiting
- State University of Londrina
-
Contact:
- Edílson S Cyrino, PhD
- Phone Number: 55 43 9139-4509
- Email: edilsoncyrino@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 60 years of age or older;
- physically independent;
- not have cardiovascular, musculoskeletal or metabolic limitations that prevent the practice of physical exercises or the execution of motor tests;
- not being on hormone replacement therapy;
- not being involved in physical exercise more than once a week, over the six months prior to the start of the study.
Exclusion Criteria:
- not participating in at least 85% of the training and not attending the assessments.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group = participants maintained their usual activities normally
Participants maintained their ususal activities normally
|
|
|
Experimental: exercise group = participants performed two years of strength training
Participants will performed two years of strength training
|
the RT program will consist of eight exercises for different body segments, namely: vertical bench press, horizontal leg press, low row, leg extension, scott curl, leg curl, triceps pulley and seated calf raise.
Every 12 weeks of training, the program will be restructured with changes in the order in which the exercises are performed, the number of sets, the number of repetitions or the training system in an attempt to avoid a supposed adaptive plateau.
The protocols in each stage will follow the recommendations for prescribing RT for the elderly, aiming at improving strength and hypertrophy, namely: a combination of single-joint and multi-joint exercises (free weights and machines), slow or moderate execution speed (ratio 1:2 for concentric and eccentric muscle actions, respectively), one to three sets of multiple repetitions, 8-12 RM or 10-15 RM, with recovery intervals between sets of one to two minutes, and a training frequency of two to three weekly sessions, on alternate days.
Other Names:
Participants will maintain their daily activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Fat
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Dual-energy x-ray absorptiometry examinations were performed in a Lunar Prodigy device, model NRL 41990 (General Electric, Madison, WI), to determine the total, regional lean soft tissue (LST), appendicular LST (ALST), and the total body, trunk, gynoid, and android fat masses (all these outcomes are presented in kilograms).
Participants were instructed to remove all metal objects before scanning to minimize possible estimation errors.
Scans were performed with participants lying in the supine position along the table's longitudinal centerline axis.
Feet were secured together at the toes to immobilize the legs while the hands were maintained in a pronated position within the scanning region.
A skilled researcher carried out both calibration and analysis, following the manufacturer's recommendations.
The software generated standard lines that separated the limbs from the trunk and head.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Muscle mass
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Dual-energy x-ray absorptiometry examinations were performed in a Lunar Prodigy device, model NRL 41990 (General Electric, Madison, WI), to determine the total, regional lean soft tissue (LST), appendicular LST (ALST), and the total body, trunk, gynoid, and android fat masses (all these outcomes are presented in kilograms).
Participants were instructed to remove all metal objects before scanning to minimize possible estimation errors.
Scans were performed with participants lying in the supine position along the table's longitudinal centerline axis.
Feet were secured together at the toes to immobilize the legs while the hands were maintained in a pronated position within the scanning region.
A skilled researcher carried out both calibration and analysis, following the manufacturer's recommendations.
The software generated standard lines that separated the limbs from the trunk and head.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular risk factors
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
HDL-c (mg/dL), LDL-c (mg/dL), Total cholesterol (mg/dL), Glucose (mg/dL), triglycerides(mg/dL), C-reactive protein (mg/dL)
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Cardiac function
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Echocardiography exams were performed accord- ing to current guidelines [18], at baseline and the end of the investigation, by an experienced echocardi- ographer blinded to patient status and group assign- ment, using a Philips ultrasound machine, model iE33 (Philips Medical Solutions, Noord Brabant, The Netherlands), equipped with an S5-1 and X5-1 transducer.
According to current recommendations, cardiac chamber dimensions, volumes, and left ven- tricular mass were measured.
Mitral inflow velocities were assessed using a pulsed-wave Doppler in the apical four-chamber view, with the sample volume placed between the tips of the mitral leaflets; veloci- ties were recorded at end-expiration.
Tissue Doppler velocities were acquired at end-expiration, in the api- cal four-chamber view, with the sample positioned at the septal and lateral mitral annulus for determination of systolic (S'), early diastolic (E'), and late diastolic (A') velocities.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
MoCA
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
The Brazilian version ofthe Montreal Cognitive Assessment (MoCA) was used to analyze the global cognitive function.
The MoCA is a screening tool composed of 12 individually punctuated tasks grouped into eight cognitive domains.
The total score ranges from 0 to 30 (higher values reflect better cognition).
Cognitive domains and their respective punctuations are as follows: short-term memory (delayed recall, 5 points); visuospatial abilities (cube drawing, 1 point, clock drawing, 3 points); executive function (trail making test, 1 point; phonemic verbal fluency, 1 point; verbal abstraction, 2 points); attention, concentration, andwork- ing memory (cancelation, 1 point; subtraction, 3 points; digit span, 2 points); language (naming, 3 points; sentence repetition, 2 points); and orientation to time (3 points) and space (3 points).
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Stroop test
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
The Stroop test version used in the present study consisted of 36 tasks.
In every trial, one cue appeared at the top part of the screen and the bottom two response options, one matched and one mismatched.
Participants had to press the directional button (< or >) corresponding to the position ofthe correct response as quickly and accurately as possible.
The test consisted of three stages with 12 trials each: (I-congruent) an inked rect- angle (green, black, red, or blue) appeared, and participants had to choose the response corresponding to the ink name; (II- neutral) a color name (green, black, red, or blue) appeared in white ink, and participants had to choose the option corresponding to the color name; (III-incongruent) a color name appeared at the top of the screen in a different ink color (e.g., the word black in green ink).
The participants had to respond to the ink color, not the color name (e.g., green in this example).
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Set shifting
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
The Trail Making Tests parts A and B were used to assess set shifting.
Part A assesses the psychomotor speed and requires the participant to draw lines that connect encircled numbers sequentially, such as drawing a line from 1 to 2, 2 to 3, 3 to 4, and so on.
Part B consists ofencircled numbers and letters.
Participants were instructed to draw a line as quickly and as accurately as possible from 1 to A, A to 2, 2 to B, B to 3, and so on, until they completed the task.
We recorded the time (in seconds) they took to complete each task.
We calculated the difference between part B and part A completion times to index set shifting.
Smaller difference scores indicate better set shifting.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Verbal fluency tasks
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Participants were asked to say asmany words as possible within 60 s (31).
In the first trial, par- ticipants had to produce words starting with the letter "F" (letter fluency) and produce the name of animals (category fluency).
The final score refers to the number ofwords correctly spoken in 60 s.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Depressive symptoms
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
The 15-item Geriatric Depres- sion Scale (GDS-15): The GDS-15 comprises 15 dichotomic items (yes or not) concerning different characteristics of geriatric depression as cognitive decline and somatic symptoms, with the final score ranging from 0 to 15, where the higher scores are worse.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Anxiety symptoms
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Beck Anxiety Inventory (BAI): The BAI comprises 21 items (statements) about different anxiety symptoms with a 4-point Likert scale, with the final score ranging from 0 to 63, where the higher scores are worse.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
|
Bone
Time Frame: from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Dual-energy x-ray absorptiometry examinations were performed in a Lunar Prodigy device, model NRL 41990 (General Electric, Madison, WI), to determine the total and regional bone mineral density (cm/m²).
Participants were instructed to remove all metal objects before scanning to minimize possible estimation errors.
Scans were performed with participants lying in the supine position along the table's longitudinal centerline axis.
Feet were secured together at the toes to immobilize the legs while the hands were maintained in a pronated position within the scanning region.
A skilled researcher carried out both calibration and analysis, following the manufacturer's recommendations.
The software generated standard lines that separated the limbs from the trunk and head.
|
from begining (November 2023) to the end 48 weeks of resistance training (November 2026)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Dos Santos L, Cyrino ES, Antunes M, Santos DA, Sardinha LB. Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function. J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):245-250. doi: 10.1002/jcsm.12160. Epub 2016 Nov 8.
- Nabuco HCG, Tomeleri CM, Sugihara Junior P, Fernandes RR, Cavalcante EF, Antunes M, Ribeiro AS, Teixeira DC, Silva AM, Sardinha LB, Cyrino ES. Effects of Whey Protein Supplementation Pre- or Post-Resistance Training on Muscle Mass, Muscular Strength, and Functional Capacity in Pre-Conditioned Older Women: A Randomized Clinical Trial. Nutrients. 2018 May 3;10(5):563. doi: 10.3390/nu10050563.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 23, 2023
Primary Completion (Estimated)
December 20, 2025
Study Completion (Estimated)
November 23, 2026
Study Registration Dates
First Submitted
September 12, 2024
First Submitted That Met QC Criteria
September 27, 2024
First Posted (Actual)
October 1, 2024
Study Record Updates
Last Update Posted (Actual)
October 1, 2024
Last Update Submitted That Met QC Criteria
September 27, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- GEPEMENE 2024b
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging Disorder | Aging, HealthyFrance
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University College CorkRecruitingDepressive Disorder, MajorIreland
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of
-
Uskudar UniversityCompleted
-
Yuksek Ihtisas UniversityCompletedDementia | Frailty | Cognitive Function | Reaction Time | Aerobic Exercise | Balance ExerciseTurkey
-
National Taiwan Normal UniversityCompletedAging | Cognitive DeclineTaiwan
-
Wayne State UniversityUnknown